세계의 경피흡수형 피부 패치 시장 보고서(2025년)

Transdermal skin patches represent a drug delivery method wherein a predetermined dose of medication is administered through an adhesive patch, absorbing into the bloodstream via the skin. These patches offer a precise and predetermined dosage of medication, facilitating absorption through the skin into the bloodstream.

The primary categories within the transdermal skin patches market include fentanyl transdermal patches, nicotine transdermal patches, buprenorphine transdermal patches, clonidine transdermal patches, oxybutynin transdermal patches, and others. Nicotine transdermal skin patches are designed to aid individuals in quitting smoking by providing a controlled source of nicotine through the skin, helping alleviate withdrawal symptoms associated with smoking cessation. Various products in this market utilize matrix, drugs in the adhesive, reservoir, and vapor technologies, catering to applications such as pain relief, nicotine cessation, hormone replacement therapy, as well as addressing neurological and cardiovascular disorders, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The transdermal skin patches market research report is one of a series of new reports from The Business Research Company that provides transdermal skin patches market statistics, including transdermal skin patches industry global market size, regional shares, competitors with a transdermal skin patches market share, detailed transdermal skin patches market segments, market trends and opportunities, and any further data you may need to thrive in the transdermal skin patches industry. This transdermal skin patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transdermal skin patches market size has grown steadily in recent years. It will grow from $7.46 billion in 2024 to $7.65 billion in 2025 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, strong economic growth in emerging markets, the increase in pharmaceutical r&d expenditure and increased healthcare expenditure.

The transdermal skin patches market size is expected to see steady growth in the next few years. It will grow to $9.18 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to the increase in smoking cessation, the rapid growth in the aging population, the increasing healthcare expenditure and the increase in cardiovascular diseases. Major trends in the forecast period include technological advancement in transdermal skin patches, advancements in diabetes transdermal patches, robust research and development activities, product innovation, collaborations and partnerships, wearable skin patches, advancements in microneedle patches for vaccination and new iontophoresis patches.

The forecast of 4.7% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of trade restrictions may challenge U.S. pain management centers by increasing costs of fentanyl matrix patches and transdermal delivery systems manufactured in Germany and Switzerland, compromising chronic pain treatment options. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cardiovascular disease is anticipated to drive the growth of the transdermal skin patches market in the future. Cardiovascular diseases affect the heart and blood vessels and are often associated with the buildup of fatty deposits in the arteries (atherosclerosis) and an increased risk of blood clots. Transdermal skin patches are utilized to prevent angina (chest pain) in individuals with coronary artery disease, characterized by narrowed blood vessels supplying the heart. They also enhance bioavailability in the treatment of heart failure. For instance, in August 2022, a report from the American College of Cardiology, a U.S.-based non-profit medical association, projected that all four cardiovascular risk factors in the United States would rise between 2025 and 2060. The most significant increase is expected in diabetes, with a 39.3% rise to 55 million individuals, followed by dyslipidemia (up 27.6% to 126 million), hypertension (up 25.1% to 162 million), and obesity (up 18.3% to 126 million). The research also indicated that the most substantial projected increases in cardiovascular disease rates would be for stroke (up 33.8% to 15 million) and heart failure (up 33.4% to 13 million), along with ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million). Consequently, the growing prevalence of cardiovascular disease is propelling the expansion of the transdermal skin patches market.

The growth of the transdermal skin patches market is significantly influenced by advancements in modern technologies. These technological advances are expanding the range of drugs that can be delivered transdermally, encompassing small molecule hydrophobic drugs, hydrophilic drugs, and macromolecules. The enhanced technological capabilities contribute to increased efficiency and the broader adoption of transdermal drug delivery systems (TDDS), consequently elevating the popularity and demand for TDDS. For instance, in September 2022, Corium, a biopharmaceutical company based in the United States, introduced Adlarity, a transdermal patch designed for Alzheimer's treatment. Utilizing the unique Corplex technology, Adlarity provides controlled and sustained release of donepezil, benefiting individuals with Alzheimer's-related dementia across various severity levels.

Leading companies in the transdermal skin patches market are intensifying their focus on introducing innovative products and securing approvals to establish a competitive advantage. Innovative products refer to novel or improved solutions addressing existing problems or needs, such as drugs or medical devices. In March 2022, Noven Pharmaceuticals Inc., a U.S.-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for XELSTRY (dextroamphetamine) transdermal system. This marked the first and only approved amphetamine patch for treating ADHD (Attention-Deficit or Hyperactivity Disorder). XELSTRYM, intended for use two hours before the required effect, provides sustained release for nine hours, allowing for personalized dosages based on clinical response and tolerability.

Major companies in the transdermal skin patches market are increasingly pursuing acquisitions and collaborations to strengthen and broaden their presence for market growth. These strategic mergers and acquisitions, along with collaborations, enable companies to leverage new technologies, helping them gain a competitive edge. For example, in August 2022, LTS LOHMANN Therapie-Systeme AG, a Germany-based firm specializing in medical adhesive technologies, acquired Tapemark Inc. for an undisclosed amount. This acquisition allows Tapemark's St. Paul facility to integrate into LTS's global operations network, complementing LTS's existing facilities in Germany and West Caldwell, NJ, in the U.S. Tapemark Inc. is a U.S.-based manufacturer of transdermal skin patches used for delivering medications through the skin.

In January 2022, Cumberland Pharmaceuticals Inc., a U.S.-based specialty pharmaceutical company, acquired Sancuso, a granisetron transdermal patch, from Kyowa Kirin for $13.5 million. This transaction granted Cumberland the U.S. rights to SANCUSO, enabling full control over its commercial aspects, including marketing, distribution, manufacturing, and medical support. SANCUSO, developed by Kyowa Kirin, is a transdermal patch delivering granisetron, a serotonin-3 (5-HT3) receptor antagonist, to prevent chemotherapy-induced nausea and vomiting (CINV).

Major companies operating in the transdermal skin patches market include Novartis, Hisamitsu Pharmaceutical Co., Inc, Henan Lingrui Pharmaceutical, Teva Pharmaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc, 3M Company, Acrux Ltd, Access Pharmaceuticals Inc, Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy's Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Europlaz Technologies Ltd, Zentiva, Medical-Lomza Sp. z o.o., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Endo Pharmaceuticals Inc.

North America was the largest region in the global transdermal skin patches market in 2024. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the transdermal skin patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The transdermal skin patches market consists of sales of single-layer drug-in-adhesive, multi-layer drug-in-adhesive, and vapor patch. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Skin Patches Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transdermal skin patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal skin patches ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transdermal skin patches market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor
• 2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types
• 3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications
• Subsegments:
• 1) By Matrix: Drug-in-matrix Patches; Polymer Matrix Patches
• 2) By Drug In Adhesive: Adhesive Matrix Patches With The Drug Incorporated In The Adhesive Layer
• 3) By Reservoir: Drug Reservoir Patches With A Separate Compartment For The Drug; Multi-layer Reservoir Patches
• 4) By Vapor: Vapor Patches That Release Active Ingredients In Vapor Form; Transdermal Patches Utilizing Vaporization Technology
• Companies Mentioned: Novartis; Hisamitsu Pharmaceutical Co., Inc; Henan Lingrui Pharmaceutical; Teva Pharmaceuticals; Luye Pharma Group Ltd; Purdue Pharma L.P.; Nitto Denko Corporation; AdhexPharma; Noven Pharmaceuticals; Teikoku Pharma; Mylan Pharmaceuticals Inc; 3M Company; Acrux Ltd; Access Pharmaceuticals Inc; Rusan Pharma; Glenmark Pharmaceuticals; Cipla Ltd; Mundipharma; Dr Reddy's Laboratories; Chattem; Clarity Medical; Welcare Industries S.P. A; F.L. Medical S.r.l; Europlaz Technologies Ltd; Zentiva; Medical-Lomza Sp. z o.o.; Johnson & Johnson; Boehringer Ingelheim GmbH; Bayer AG; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Endo Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transdermal Skin Patches Market Characteristics

3. Transdermal Skin Patches Market Trends And Strategies

4. Transdermal Skin Patches Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Transdermal Skin Patches Growth Analysis And Strategic Analysis Framework

• 5.1. Global Transdermal Skin Patches PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Transdermal Skin Patches Market Growth Rate Analysis
• 5.4. Global Transdermal Skin Patches Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Transdermal Skin Patches Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Transdermal Skin Patches Total Addressable Market (TAM)

6. Transdermal Skin Patches Market Segmentation

• 6.1. Global Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Matrix
• Drug In Adhesive
• Reservoir
• Vapor
• 6.2. Global Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fentanyl Transdermal Patch
• Nicotine Transdermal Patch
• Buprenorphine Transdermal Patch
• Clonidine Transdermal Patch
• Oxybutynin Transdermal Patch
• Other Types
• 6.3. Global Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Relief
• Nicotine Cessation
• Hormone Replacement Therapy
• Neurological Disorders
• Cardiovascular Disorders
• Other Distribution Channels
• 6.4. Global Transdermal Skin Patches Market, Sub-Segmentation Of Matrix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-In-Matrix
• Monolithic Matrix
• Laminated Matrix
• 6.5. Global Transdermal Skin Patches Market, Sub-Segmentation Of Drug In Adhesive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Layer Drug In Adhesive
• Multi-Layer Drug In Adhesive
• 6.6. Global Transdermal Skin Patches Market, Sub-Segmentation Of Reservoir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Membrane-Controlled Reservoir
• Pressure-Sensitive Reservoir
• Gel Reservoir
• 6.7. Global Transdermal Skin Patches Market, Sub-Segmentation Of Vapor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transdermal Vapor Patches
• Self-Activated Vapor Patches
• Vapor Dispensing Systems

7. Transdermal Skin Patches Market Regional And Country Analysis

• 7.1. Global Transdermal Skin Patches Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Transdermal Skin Patches Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transdermal Skin Patches Market

• 8.1. Asia-Pacific Transdermal Skin Patches Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transdermal Skin Patches Market

• 9.1. China Transdermal Skin Patches Market Overview
• 9.2. China Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transdermal Skin Patches Market

• 10.1. India Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transdermal Skin Patches Market

• 11.1. Japan Transdermal Skin Patches Market Overview
• 11.2. Japan Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transdermal Skin Patches Market

• 12.1. Australia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transdermal Skin Patches Market

• 13.1. Indonesia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transdermal Skin Patches Market

• 14.1. South Korea Transdermal Skin Patches Market Overview
• 14.2. South Korea Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transdermal Skin Patches Market

• 15.1. Western Europe Transdermal Skin Patches Market Overview
• 15.2. Western Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transdermal Skin Patches Market

• 16.1. UK Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transdermal Skin Patches Market

• 17.1. Germany Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transdermal Skin Patches Market

• 18.1. France Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transdermal Skin Patches Market

• 19.1. Italy Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transdermal Skin Patches Market

• 20.1. Spain Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transdermal Skin Patches Market

• 21.1. Eastern Europe Transdermal Skin Patches Market Overview
• 21.2. Eastern Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transdermal Skin Patches Market

• 22.1. Russia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transdermal Skin Patches Market

• 23.1. North America Transdermal Skin Patches Market Overview
• 23.2. North America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transdermal Skin Patches Market

• 24.1. USA Transdermal Skin Patches Market Overview
• 24.2. USA Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transdermal Skin Patches Market

• 25.1. Canada Transdermal Skin Patches Market Overview
• 25.2. Canada Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transdermal Skin Patches Market

• 26.1. South America Transdermal Skin Patches Market Overview
• 26.2. South America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transdermal Skin Patches Market

• 27.1. Brazil Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transdermal Skin Patches Market

• 28.1. Middle East Transdermal Skin Patches Market Overview
• 28.2. Middle East Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transdermal Skin Patches Market

• 29.1. Africa Transdermal Skin Patches Market Overview
• 29.2. Africa Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transdermal Skin Patches Market Competitive Landscape And Company Profiles

• 30.1. Transdermal Skin Patches Market Competitive Landscape
• 30.2. Transdermal Skin Patches Market Company Profiles
  • 30.2.1. Novartis Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Hisamitsu Pharmaceutical Co., Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Henan Lingrui Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Luye Pharma Group Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Transdermal Skin Patches Market Other Major And Innovative Companies

• 31.1. Purdue Pharma L.P.
• 31.2. Nitto Denko Corporation
• 31.3. AdhexPharma
• 31.4. Noven Pharmaceuticals
• 31.5. Teikoku Pharma
• 31.6. Mylan Pharmaceuticals Inc
• 31.7. 3M Company
• 31.8. Acrux Ltd
• 31.9. Access Pharmaceuticals Inc
• 31.10. Rusan Pharma
• 31.11. Glenmark Pharmaceuticals
• 31.12. Cipla Ltd
• 31.13. Mundipharma
• 31.14. Dr Reddy's Laboratories
• 31.15. Chattem

32. Global Transdermal Skin Patches Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transdermal Skin Patches Market

34. Recent Developments In The Transdermal Skin Patches Market

35. Transdermal Skin Patches Market High Potential Countries, Segments and Strategies

• 35.1 Transdermal Skin Patches Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Transdermal Skin Patches Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Transdermal Skin Patches Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer